openPR Logo
Press release

Accelerating Sales in North America to Drive the Adventitious Agent Testing market between 2020 and 2030

11-30-2020 10:05 AM CET | Health & Medicine

Press release from: Persistence Market Research

Adventitious agents are microorganisms that have unintentionally introduced into the manufacturing of biological products. They mainly include fungi, mycoplasmas, rickettsia, protozoa, bacteria, parasites, and viruses. Adventitious agents testing is a process of detection by a combination of methods at various stages of biologics production. Adventitious agents are a major concern while using mammalian cell lines for the production of biologics. They are two types of testing methods namely Specific and Non-specific methods. In the Specific method, the adventitious agents are known e.g. PCR. In the Non-specific method, the adventitious agents are known and unknown, and it is subdivided into three types. A) In Vivo (Animals) b) In Vitro (Cell Cultures) c) Molecular/Biochemical. In In-vivo methods, various animal species are used, like a guinea pig, rabbits, adult mice and suckling mice, etc. In-Vivo methods are used because they detect viruses not readily possible with other systems. The in-vitro method is based on the ability of culture to grow a wide array of pathogens and also based on their extensive use in detection of human pathogens. Others Non-specific methods include Transmission Electron Microscopy and Reverse Transcriptase (RT) Assay for Retroviruses. (Source: FDA)

For more insights into the Market, request a sample of this report @ https://www.persistencemarketresearch.com/samples/15445

Adventitious Agent Testing Market: Drivers and Restraints

Rising concerns of contamination in biological products and the need for improvement of quality control measures for biologicals are drivers boosting the burgeoning growth of the adventitious agent testing market. Adventitious agent testing methods are continuously evolving and represent the improvement in technology, including throughput and sensitivity. These technological advancements have potential to support safe biologicals developments, all these factors boosting the growth of the adventitious agent testing market. Manufacturers of a large class biologicals products, including vaccines and cell therapy products, often require cell substrates from animal origin. There is a high potential risk that cell substrates and raw materials of biologicals products can contaminated with adventitious agents. So, there is a high need for adventitious agent testing to assure quality and safety of biological substances. This demand fuels the growth of the adventitious agent testing market.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/15445

Evaluation of risk associated with new viruses by using present evolving technology limits the application of present adventitious agents testing. Issues in uses of assays and various national regulatory authorities harmonization act as a restraint on the growth of the adventitious agent testing market.

Adventitious Agent Testing Market: Segmentation

Segmentation based on Type

Specific Method
g. PCR
Non-Specific Method
In-Vivo (Animal)
In-Vitro (Cell Cultures)
Molecular/Biochemical
Segmentation based on End User

Biotechnology Companies
Research Institutes
CRO’s
Research Laboratories
To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/15445

Adventitious Agent Testing Market: Market Overview

Selection of cell substrate influence purity and safety of the biologics manufactured in it. The evaluation is specifically tailored to the vaccine product and cell substrate to be developed to assure purity and safety. Because of increasing vulnerability to microbial contamination of biological products, there is a high demand for adventitious agent testing which is expected to boost the growth of the market. The market has witnessed robust growth due to increasing adventitious agents and vaccines is pertinent in the context of day-by-day emerging infectious diseases. Improving government funding and increasing research institution contribution in innovation are expected to fuel the growth. The future of Adventitious Agent Testing Market anticipated with double CAGR during the forecasted period.

Adventitious Agent Testing Market: Region-wise Overview

Global Adventitious Agent Testing Market segmented into North America, Europe, Asia -Pacific & Japan, The Middle East and Africa regions and Latin America by region wise. North America dominates the global Adventitious Agent Testing Market due to increasing research contribution in new biological product development, and in North America, USA is a major shareholder. Europe and Asia-pacific are the fastest growing market in Adventitious Agent Testing Market due to increasing support of the government and funding organizations in these regions. The Middle East and Africa regions and Latin America are also showing least growth comparatively during the forecasted period.

Adventitious Agent Testing Market: Key Participants

The key participants in Adventitious Agent Testing Market are Charles River Laboratories International, Inc., Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc, etc. The companies are mainly focusing on collaboration and partnership to keep up the pace of the competitiveness and to acquire new markets.

Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Accelerating Sales in North America to Drive the Adventitious Agent Testing market between 2020 and 2030 here

News-ID: 2198553 • Views:

More Releases from Persistence Market Research

HIV AIDS Testing Market Sales Estimated to Hit USD 6.6 Billion by 2032| Says Persistence Market Research
HIV AIDS Testing Market Sales Estimated to Hit USD 6.6 Billion by 2032| Says Per …
Introduction The HIV AIDS testing market has gained significant importance in recent years due to the global focus on early diagnosis, prevention, and management of HIV infections. Timely and accurate testing plays a crucial role in reducing transmission rates, improving patient outcomes, and supporting public health initiatives worldwide. With advancements in diagnostics, including rapid tests, ELISA, and molecular assays, HIV testing has become more accessible, reliable, and efficient across healthcare settings. For
Urinary Catheters Market to Surge at 5.6% CAGR, Hitting US$ 3.1 Bn by 2032, According to PMR Study
Urinary Catheters Market to Surge at 5.6% CAGR, Hitting US$ 3.1 Bn by 2032, Acco …
Introduction The urinary catheters market has witnessed significant growth in recent years, driven by its essential role in managing urinary retention, incontinence, surgical interventions, and other urological disorders. Urinary catheters are widely used across hospitals, long-term care facilities, and home healthcare settings due to their effectiveness in draining urine from the bladder and supporting patients with chronic or temporary urinary complications. Known for their clinical importance, adaptability, and availability in various
3D Bioprinting Market Size is Expected to Reach 7.39 Billion by 2032, Rising at a Market Growth of 15% CAGR During the Forecast Period
3D Bioprinting Market Size is Expected to Reach 7.39 Billion by 2032, Rising at …
Introduction The 3D bioprinting market has gained significant momentum in recent years due to its transformative potential in healthcare, pharmaceutical research, and regenerative medicine. Known for its ability to precisely fabricate complex biological structures, 3D bioprinting is widely applied in areas such as tissue engineering, organ regeneration, drug testing, and personalized medicine. By enabling the creation of living tissues with high accuracy, this technology is revolutionizing research capabilities and paving the
Viral Molecular Diagnostic Market to Grow at a CAGR of 9.0% from 2025 to 2032, reaching US$ 7.3 Bn as per PMR Study
Viral Molecular Diagnostic Market to Grow at a CAGR of 9.0% from 2025 to 2032, r …
Introduction The viral molecular diagnostic market has gained substantial traction in recent years due to its critical role in the accurate detection and management of viral infections. Known for their precision, speed, and ability to identify genetic material of viruses, molecular diagnostic tests are widely used across healthcare facilities, research laboratories, and point-of-care settings. These diagnostics provide effective solutions for early disease detection, monitoring of treatment efficacy, and outbreak control, ensuring

All 5 Releases


More Releases for Adventitious

Comprehensive Market Forecast for Adventitious Agent Testing: Market Analysis an …
Adventitious Agent Testing Market Insights: Trends, Drivers, and Outlook 2024 - 2031 Adventitious Agent Testing Market Scope: Unveiling Today's Trends Adventitious Agent Testing refers to the assessment of unintended organisms, such as viruses and bacteria, in therapeutic products. This market is driven by the increasing demand for biologics and the growing emphasis on product safety in the biopharmaceutical sector. Regulatory agencies are tightening guidelines, necessitating robust testing frameworks to ensure the integrity
USD 6.83 Billion Global Biologics Safety Testing Market Size is Expected to Grow …
Findings from the report "Biologics Safety Testing Market By Product (Services, Instruments and Reagents, and Kits); by Test Type (Bioburden tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests, and Other Test Types); by Application (Tissue and Tissue-related Products Testing, Cell It is estimated that the market will expand at a compound annual growth rate (CAGR) of over 11.5%
Global Biologics Safety Testing Market Key Players, Size, Share Demands, Trends, …
Global Biologics Safety Testing Market was valued at USD 3463.90 Million in the year 2020. Major factors driving the growth of this market are the growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science sector, increasing number of drug launches, high incidence and large economic burden of chronic diseases. In the coming years, emerging markets and increasing pharmaceutical outsourcing
The Adventitious Agent Testing market to be in conjunction to growth from 2017 t …
Adventitious agents are microorganisms that have unintentionally introduced into the manufacturing of biological products. They mainly include fungi, mycoplasmas, rickettsia, protozoa, bacteria, parasites, and viruses. Adventitious agents testing is a process of detection by a combination of methods at various stages of biologics production. Adventitious agents are a major concern while using mammalian cell lines for the production of biologics. They are two types of testing methods namely Specific and
The Adventitious Agent Testing market to inundate between 2020 and 2030
Adventitious agents are microorganisms that have unintentionally introduced into the manufacturing of biological products. They mainly include fungi, mycoplasmas, rickettsia, protozoa, bacteria, parasites, and viruses. Adventitious agents testing is a process of detection by a combination of methods at various stages of biologics production. Adventitious agents are a major concern while using mammalian cell lines for the production of biologics. They are two types of testing methods namely Specific and
Adventitious Agent Testing Market Poised for Steady Growth in the Future
Adventitious agents, as defined by the World Health Organization, are organisms such as virus, parasites, and fungi which are unintentionally introduced into the manufacturing process of biological medicinal products. Biotechnological products such as vaccines are vital health medicinal products, thus their safety and quality are of utmost importance for public health. Production of vaccine or other biotechnological products bears the risk of getting contaminated due to adventitious agents. Therefore, detection